aTYR PHARMA INC

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

aTYR PHARMA INC filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. aTyr Pharma Advancing tRNA synthetase biology Efzofitimod in Pulmonary Sarcoidosis and Beyond June 2026 © 2026 aTyr Pharma Exhibit 99. 1 Forward-Looking Statements The following slides and any accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securiti…